Veritas UK Improving healthcare through geneticsVeritas is a LetsGetChecked company, a leading healthcare solutions company; guided by science, empowered by technology and passionate about caring for people.Veritas is The Genome Company; the first company to offer clinical-grade Whole Genome Sequencing (WGS) and interpretation for healthy individuals. Empowering people to live longer and happier lives Global leaders in WGS and WES Transforming healthcare through advanced genetic and clinical interpretation. Pioneers in Genomics Operating in more than 35 countries around the world, democratizing access to genomic data and its benefits. Cutting-edge laboratories With the most advanced sequencing technology together with an expert team specializing in variant analysis.Preventive genetics services Whole Genome Sequencing based comprehensive genetic risk screening analysis designed for healthy individuals. First genetic analysis designed to integrate genomics into a patient’s health check-ups, enabling personalization of medical care. We analyze information recommended byleading genetics societies as well as information related to actionable diseases that can be prevented or better managed through early detection.myGenome includes:Download Brochure Acquire test Polygenic risk score assessment that provides information regarding patient risk for common multifactorial diseases. Multi – Polygenic risk score assessment that provides information regarding patient risk for common multifactorial diseases.myHealthScore includes:Download Brochure Acquire test Genetic test that identifies specific variants using whole exome sequencing (WES) to tailor a patient’s current and future drug prescription. The report includes an analysis of specific variants in 25 genes associated with 129 active ingredients, including brief recommendations based on clinical guidelines.Medical areas of the reportDownload Brochure Acquire test This panel is an advanced genetic test that analyses 17 genes known to significantly increase an individual’s risk of developing hereditary breast, gynaecological and colorectal cancer, among others. This panel’s accelerated turnaround time provides clinicians with crucial genetic information that can be used, together with the patient’s clinical information, to aid informed decisions about prevention or treatment.Genes included:Download Brochure Acquire testHow it works?Contact us